Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms, mainly the C677T, have been implicated as risk factors for several cancers as the acute lymphoblastic leukemia (ALL). In addition, a potential effect of such variant on the efficacy of methotrexate (MTX) has been reported.
Objective
In this study, we evaluated the impact of the C677T variant of MTHFR on MTX-related toxicity in ALL patients from Tunisia; to provide new insights for a personalized therapy based on the human genotype.
Materials and methods
Genotyping was carried out with restriction fragment length polymorphism (RFLP) on blood samples from a total of 35 younger patients; suffering from ALL.
Results
In the ALL patients, the MTHFR 677CT genotype confers a greater risk of toxicity with 1.3 times as relative risk mainly the hepatic toxicity when compared with MTHFR 677CC.
Conclusion
Our findings suggest that C677T polymorphism of MTHFR seems to be a good marker for MTX-related toxicity in ALL.
TomizawaD. Acute leukemia in adolescents and young adults. Rinsho Ketsueki2017; 58: 2160–2167.
2.
ZhuCLiuYWWangSZet al.Associations between the C677T and A1298C polymorphisms of MTHFR and the toxicity of methotrexate in childhood malignancies: a meta-analysis. Pharmacogenomics J2018; 18: 450–459.
3.
YaoPHeXZhangRet al.The influence of MTHFR genetic polymorphisms on adverse reactions after methotrexate in patients with hematological malignancies: a meta-analysis. Hematology2019; 24(1): 10–19.
4.
HadhriSRejabMBGuedriaHet al.Factor V Leiden, prothrombin 20210G>A, MTHFR 677C>T and 1298A>C, and homocysteinemia in Tunisian blood donors. J Clin Lab Anal2012; 26: 167–173.
5.
FrikhaRBouayedNBen RhoumaBet al.A duplex polymerase chain reaction-restriction fragment length polymorphism for rapid screening of methylenetetrahydrofolate reductase gene variants: genotyping in acute leukemia. J Clin Lab Anal2018; 32: e22198–e22198.
6.
LadasEJOrjuelaMStevensonKet al.Dietary intake and childhood leukemia: The Diet and Acute Lymphoblastic Leukemia Treatment (DALLT) cohort study. Nutrition2016; 32: 1103–1109.e1.
7.
MahmoudLBMdhaffarMFrikhaRet al.Use of MTHFR C677T polymorphism and plasma pharmacokinetics to predict methotrexate toxicity in patients with acute lymphoblastic leukemia. Adv Clin Exp Med2018; 27: 1061–1068.
8.
KaluznaEStraussEZajac-SpychalaOet al.Functional variants of gene encoding folate metabolizing enzyme and methotrexate-related toxicity in children with acute lymphoblastic leukemia. European Journal of Pharmacology2015; 769: 93–99.
9.
UmerezMGutierrez-CaminoAMunoz-MaldonadoCet al.MTHFR polymorphisms in childhood acute lymphoblastic leukemia: influence on methotrexate therapy. Pharmgenomics Pers Med2017; 10: 69–78.
10.
YangLHuXXuL. Impact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on methotrexate-induced toxicities in acute lymphoblastic leukemia: a meta-analysis. Tumour Biol2012; 33: 1445–1454.
11.
HeHRChenSYYouHSet al.Association between methylenetetrahydrofolate reductase polymorphisms and the relapse of acute lymphoblastic leukemia: a meta-analysis. Pharmacogenomics J2014; 14: 432–438.
12.
FukushimaHFukushimaTSakaiAet al.Polymorphisms of MTHFR associated with higher relapse/death ratio and delayed weekly MTX administration in pediatric lymphoid malignancies. Leuk Res Treatment2013; 2013: 238528–238528.
13.
LiuSGLiZGCuiLet al.Effects of methylenetetrahydrofolate reductase gene polymorphisms on toxicities during consolidation therapy in pediatric acute lymphoblastic leukemia in a Chinese population. Leuk Lymphoma2011; 52: 1030–1040.
14.
El-KhodaryNMEl-HaggarSMEidMAet al.Study of the pharmacokinetic and pharmacogenetic contribution to the toxicity of high-dose methotrexate in children with acute lymphoblastic leukemia. Med Oncol2012; 29: 2053–2062.
15.
TantawyAAEl-BostanyEAAdlyAAet al.Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia. Blood Coagul Fibrinolysis2010; 21: 28–34.
16.
MoulikNRKumarAAgrawalSet al.Effect of folate status and methylenetetrahydrofolate reductase genotypes on the complications and outcome of high dose methotrexate chemotherapy in north Indian children with acute lymphoblastic leukemia. Indian J Med Paediatr Oncol2016; 37: 85–89.
17.
YazıcıoğluBKayaZGuntekin ErgunSet al.Influence of folate-related gene polymorphisms on high-dose methotrexate-related toxicity and prognosis in Turkish children with acute lymphoblastic leukemia. Turk J Haematol2017; 34: 143–150.
18.
Ramírez-PachecoAMoreno-GuerreroSAlamilloIet al.Mexican childhood acute lymphoblastic leukemia: a pilot study of the MDR1 and MTHFR gene polymorphisms and their associations with clinical outcomes. Genet Test Mol Biomarkers2016; 20: 597–602.
19.
AráozHVD’AloiKFoncubertaMEet al.Pharmacogenetic studies in children with acute lymphoblastic leukemia in Argentina. Leuk Lymphoma2015; 56: 1370–1378.
